Intiva BioPharma Inc. (KDRH) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 19 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Aug 12, 2020 involved a transaction of 1,797,192 shares valued at $0.
No significant insider buying has been recorded for KDRH in the recent period.
No significant insider selling has been recorded for KDRH in the recent period.
Based on recent SEC filings, insider sentiment for KDRH is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at Intiva BioPharma Inc. (KDRH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading KDRH stock, having executed 19 transactions in the past 90 days. The most active insider is Richard S. Greenberg (Executive), who has made 6 transactions totaling $0.
Get notified when executives and directors at KDRH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 12, 2020 | S. Greenberg Richard | Executive | Conversion | 1,797,192 | $N/A | $0 | |
| Nov 29, 2017 | L. Wasoff Evan | Executive | Other | 629,128 | $N/A | $0 | |
| Nov 29, 2017 | D. Bankier Alain | Executive | Other | 1,384,083 | $N/A | $0 | |
| Nov 29, 2017 | Friedland Jeffrey | Executive | Other | 15,099,083 | $N/A | $0 | |
| Nov 29, 2017 | Friedland Jeffrey | Executive | Other | 1,258,257 | $N/A | $0 | |
| Nov 29, 2017 | Friedland Jeffrey | Executive | Other | 130,859 | $N/A | $0 | |
| Nov 29, 2017 | Inc Intiva Usa | Executive | Other | 15,099,083 | $N/A | $0 | |
| Nov 29, 2017 | S. Greenberg Richard | Executive | Other | 503,303 | $N/A | $0 | |
| Nov 29, 2017 | S. Greenberg Richard | Executive | Other | 15,099,083 | $N/A | $0 | |
| Nov 29, 2017 | I. Goldfarb Robert | Executive | Other | 644,227 | $N/A | $0 | |
| Oct 13, 2017 | Inc Intiva Usa | Executive | Other | 53,405,501 | $N/A | $0 | |
| Oct 13, 2017 | Inc Intiva Usa | Executive | Other | 20,000,000 | $N/A | $0 | |
| Oct 13, 2017 | Friedland Jeffrey | Executive | Other | 20,000,000 | $N/A | $0 | |
| Oct 13, 2017 | Friedland Jeffrey | Executive | Other | 462,848 | $N/A | $0 | |
| Oct 13, 2017 | Friedland Jeffrey | Executive | Other | 4,450,458 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 1 | $0 | 0.0% |
Other(J) | 18 | $0 | 0.0% |
Insider activity at Intiva BioPharma Inc. shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.6 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Richard S. Greenberg, has transacted $0 during this period.